1. Home /
  2. Healthcare

Healthcare

Checking Up on 5 Favorite Healthcare REITs

Checking Up on 5 Favorite Healthcare REITs

This group benefits from two trends -- declining interest rates and an aging of the population.

Select Medical Holdings Could Soon Resume Its Long-Term Uptrend

Select Medical Holdings Could Soon Resume Its Long-Term Uptrend

Let's review the charts of SEM.

Elanco to Buy Bayer's Animal Health Business for $7.6 Billion

Elanco to Buy Bayer's Animal Health Business for $7.6 Billion

Elanco says the deal, which is subject to approval from regulators, would double the size of its companion animal business.

Medtronic Rises as Heart Device Maker Pumps Out Revenue Beat

Medtronic Rises as Heart Device Maker Pumps Out Revenue Beat

Medtronic's cardiac and vascular unit generates $2.79 billion in fiscal first-quarter revenue, surpassing analysts' estimates.

Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

Endo, Allergan Nearing Deals to Limit Ohio Litigation Over Opioids - Report

Allergan is said to be discussing paying $5 million while Endo is close to an agreement to pay $10 million, according to a report.

Charts of Alcon Look Good

Charts of Alcon Look Good

Traders could go long on the eye-care company on strength above $62 risking below $59 with a $72 price target.

Prognosis Not Quite Clear for AMN Healthcare

Prognosis Not Quite Clear for AMN Healthcare

MN looks like it could move higher and rally, but the uneven trading pattern tells me to look for easier set-ups.

Walmart Climbs on Analysts' Price-Target Increases

Walmart Climbs on Analysts' Price-Target Increases

The stock of the world's biggest retailer is advancing. Several analysts increased their price targets after the company beat Wall Street's second-quarter-earnings expectations.

Care.com Jumps as Activist Investor Urges Review of Strategic Alternatives

Care.com Jumps as Activist Investor Urges Review of Strategic Alternatives

Care.com jumped after Engine Capital urged the online caregiving marketplace to explore strategic alternatives while it searches for a new CEO.

Novocure's Charts Are as Bullish As They Get, So Here's My Strategy

Novocure's Charts Are as Bullish As They Get, So Here's My Strategy

The oncology company has had a strong run and all the technical signals indicate the move higher isn't over.